Post-Approval Readiness: Takeaways from Meeting on the Mesa 2021
Read about the important dynamics involved in bringing cell and gene therapies to patients.
The Art of Successful Gene Therapy Launches
Navigating the evolving and complex healthcare data, policy, and regulatory requirements presents new challenges to patients’ access to treatment.
Breaking Down Patient Barriers to Therapy Through Mobile Messaging & Virtual Assistants
Learn how healthcare virtual assistants are coming along and where the future could point towards.
AI in Pharmacovigilance: Streamlining for the Future
Read more on the guidelines the WHO released on AI in healthcare and how that affects using AI in PV.
Effective Patient Engagement & Adherence: Do’s and Dont’s
UBC’s Director of Commercial Strategy and Client Engagement Kelly Elio, RN, discusses how effective patient engagement drives patient adherence.
From Pharmacovigilance to Vaccination Volunteering
Senior Safety Physician Ashleigh Van Dijk returned to the clinical setting to volunteer with the COVID-19 vaccination effort.
The Value of Nursing in Clinical Care Coordination
The recent global health crisis changed how clinical nursing support services are delivered and consumed.
Alleviating the Complexities of a Cell & Gene Therapy Program Through Patient Support
There must be alignment between multiple stakeholders related to collaborating and communicating for the sake of the patient’s treatment.
The Top 5 Questions to Ask When Developing a REMS
A REMS should be considered when risk mitigation efforts are required beyond product labeling and routine pharmacovigilance.
Patient Enrollment Engagement in Indications With Flare-Ups
Recent studies cite that 80% of trials are delayed due to patient recruitment challenges, with up to 20% of enrolled sites never enrolling a single patient.
